Novel compound restores immune response in patients with melanoma
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.1
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.1
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
A study has shown that disruption to cell autophagy is involved in the development of pancreatic cancer.
Recent study shows how a microscope using ultraviolet (UV) light to illuminate samples enables pathologists to assess high-resolution images of biopsies and other fresh tissue samples for disease, quickly and effectively.
Blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies...
An unexpected drug target for acute myeloid leukaemia could open new avenues to develop effective treatments against the potentially lethal disease...
The environment surrounding a tumour can trigger metastatic behaviour in cancer cells...
Researchers detail a possible way to re-engage a tumour suppressor protein, that has been found to be inactivated in triple-negative breast cancer cells...
Scientists have made a discovery that could reduce the spread of cancer by hindering a protein that binds cancer cells together and allows them to invade tissues...
Researchers have identified a protein that can be targeted to suppress the growth of a common type of breast cancer...
A synthetic double-stranded RNA has potential for use as an anti-liver cancer vaccine...
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
By stimulating a patient’s immune system, a drug already in use to treat a blood disorder can prevent the growth of a variety of solid tumours...
Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer...
Improved methods validate the use of blood samples for studying patients' cancer genomes